The Role of Bladder-Washing Cytology as an Adjunctive Method to Cystoscopy During Follow-Up for Low-Grade TaT1 Non-Muscle-Invasive Bladder Cancer

被引:0
作者
Carbonell, Enric [1 ]
Mercader, Claudia [1 ]
Alfambra, Hector [1 ]
Narvaez, Paulette [1 ]
Villalba, Eric [1 ]
Pages, Rita [1 ]
Asiain, Ignacio [1 ]
Costa, Meritxell [1 ]
Franco, Agustin [1 ]
Alcaraz, Antonio [1 ]
Ribal, Maria Jose [1 ]
Vilaseca, Antoni [1 ]
机构
[1] Hosp Clin Barcelona, Dept Urol, Villarroel 170, Barcelona 08036, Spain
关键词
non-muscle-invasive bladder cancer; urine cytology; urothelial carcinoma; cystoscopy; follow-up; URINARY CYTOLOGY; RECURRENCE; PROGRESSION; BIOMARKERS; DIAGNOSIS; MARKERS;
D O I
10.3390/cancers16213708
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objective: The role of urine cytology during follow-up for low-grade (LG) non-muscle-invasive bladder cancer (NMIBC) is not well established, although cytology has low sensitivity in detecting LG recurrences. Our study aims to evaluate the impact of urine cytology as a complementary method to cystoscopy during follow-up for LG NMIBC. Methods: Patients diagnosed with primary LG TaT1 bladder cancer (BC) between 2010 and 2020 were included. Patients were stratified according to the EAU NMIBC scoring model. Urine cytology was performed during follow-up cystoscopy. The outcomes of the study were BC recurrence and upgrading to high-grade (HG). Cytology utility was established by assessing whether its result led to management change. Results: We included 337 patients with LG TaT1 BC. EAU risk group distribution was low in 262 (77.7%), intermediate in 57 (16.9%), and high-risk in 18 (5.3%) cases. With a median follow-up of 5 years, 166 (49.3%) patients experienced recurrence. Cystoscopy was positive in 154 (92.8%) and suspicious in 12 (7.2%) cases. Urine cytology was positive in 33 (19.9%) cases but only changed management in 3 (0.89%), all with suspicious cystoscopy. Positive cytology at first recurrence was associated with higher risk of upgrading during follow-up (HR 2.781, p = 0.006) and lower upgrading-free survival (p = 0.001). Conclusions: The role of urine cytology to detect first recurrences during follow-up for primary LG TaT1 NMIBC might be limited to patients with non-conclusive lesions in the cystoscopy. A positive cytology at first recurrence is associated with a higher risk of upgrading to HG BC during follow-up.
引用
收藏
页数:9
相关论文
共 20 条
  • [1] Babjuk M., 2022, Eur. Urol, V31, P1
  • [2] The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology
    Barkan, Guliz A.
    Wojcik, Eva M.
    Nayar, Ritu
    Savic-Prince, Spasenija
    Quek, Marcus L.
    Kurtycz, Daniel F. I.
    Rosenthal, Dorothy L.
    [J]. ACTA CYTOLOGICA, 2016, 60 (03) : 185 - 197
  • [3] Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study
    Bell, Michael D.
    Yafi, Faysal A.
    Brimo, Fadi
    Steinberg, Jordan
    Aprikian, Armen G.
    Tanguay, Simon
    Kassouf, Wassim
    [J]. WORLD JOURNAL OF UROLOGY, 2016, 34 (10) : 1405 - 1409
  • [4] Bree KK, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.3050
  • [5] Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
    Chang, Sam S.
    Boorjian, Stephen A.
    Chou, Roger
    Clark, Peter E.
    Daneshmand, Siamak
    Konety, Badrinath R.
    Pruthi, Raj
    Quale, Diane Z.
    Ritch, Chad R.
    Seigne, John D.
    Skinner, Eila Curlee
    Smith, Norm D.
    McKiernan, James M.
    [J]. JOURNAL OF UROLOGY, 2016, 196 (04) : 1021 - 1029
  • [6] Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer
    Feiertag, Nathan
    Barry, Emily
    Abramson, Max
    Park, Ju-young
    Kovac, Evan
    Aboumohamed, Ahmed
    Watts, Kara
    Sankin, Alex
    [J]. CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 258 - 264
  • [7] SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE
    HENEY, NM
    AHMED, S
    FLANAGAN, MJ
    FRABLE, W
    CORDER, MP
    HAFERMANN, MD
    HAWKINS, IR
    [J]. JOURNAL OF UROLOGY, 1983, 130 (06) : 1083 - 1086
  • [8] Recurrence and progression in low grade papillary urothelial tumors
    Holmäng, S
    Hedelin, H
    Anderström, C
    Holmberg, E
    Busch, C
    Johansson, SL
    [J]. JOURNAL OF UROLOGY, 1999, 162 (03) : 702 - 707
  • [9] Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression
    Kobayashi, Hiroaki
    Kikuchi, Eiji
    Mikami, Shuji
    Maeda, Takahiro
    Tanaka, Nobuyuki
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    [J]. BMC UROLOGY, 2014, 14
  • [10] Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
    Lotan, Y
    Roehrborn, CG
    [J]. UROLOGY, 2003, 61 (01) : 109 - 118